Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 831-836

  Li, Lei ^a,b   Shi, Qing Guo ^c   Lin, Fang ^b   Liang, Yu Guang ^c   Sun, Li Jian ^b   Mu, Jin Song ^b   Wang, Yong Gang ^b   Su, Hai Bin ^b   Xu, Biao ^b   Ji, Cheng Cheng ^b   Huang, Hui Huang ^b   Li, Ke ^b   Wang, Hui Fen ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b 302 MILITARY HOSPITAL   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Citrobacter rodentium; Inflammatory bowel disease; Interleukin 6; Th17 cells

Indexed keywords

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL DIFFERENTIATION; CITROBACTER RODENTIUM; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN A; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; MICE; MICE, INBRED C57BL; PEYER'S PATCHES; SURVIVAL RATE; TH17 CELLS; WEIGHT LOSS;

EID: 84893863454     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1898     Document Type: Article

References (25)

1. Mundy R, MacDonald TT, Dougan G, Frankel G and Wiles S: Citrobacter rodentium of mice and man. Cell Microbiol 7: 1697-1706, 2005.
2. Luperchio SA and Schauer DB: Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3: 333-340, 2001.
3. Borenshtein D, McBee ME and Schauer DB: Utility of the Citrobacter rodentium infection model in laboratory mice. Curr Opin Gastroenterol 24: 32-37, 2008.
4. Kim YG, Kamada N, Shaw MH, Warner N, Chen GY, Franchi L and Núñez G: The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34: 769-780, 2011.
5. Johnson E and Barthold SW: The ultrastructure of transmissible murine colonic hyperplasia. Am J Pathol 97: 291-313, 1979.
6. Morgan ET, Goralski KB, Piquette-Miller M, et al: Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36: 205-216, 2008.
7. Neurath MF, Weigmann B, Finotto S, et al: The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195: 1129-1143, 2002.
8. Nenci A, Becker C, Wullaert A, et al: Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446: 557-561, 2007.
9. Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C and Vallance BA: MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol 10: 618-631, 2008.
10. Gibson DL, Ma C, Rosenberger CM, et al: Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 10: 388-403, 2008.
11. Lebeis SL, Bommarius B, Parkos CA, Sherman MA and Kalman D: TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol 179: 566-577, 2007.
12. Eckmann L: Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci 1072: 28-38, 2006.
13. Vallance BA, Deng W, Knodler LA and Finlay BB: Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect Immun 70: 2070-2081, 2002.
14. Shiomi H, Masuda A, Nishiumi S, et al: Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Infect Immun 78: 2653-2666, 2010.
15. Bry L and Brenner MB: Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 172: 433-441, 2004.
16. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA and Artis D: CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122-134, 2011.
17. Ishigame H, Kakuta S, Nagai T, et al: Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108-119, 2009.
18. Ivanov II, Atarashi K, Manel N, et al: Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498, 2009.
19. Chiricozzi A, Guttman-Yassky E, Suarez-Fariñas M, et al: Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131: 677-687, 2011.
20. Geddes K, Rubino SJ, Magalhaes JG, et al: Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 17: 837-844, 2011.
21. Miossec P, Korn T and Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898, 2009.
22. O'Dell JR, Elliott JR, Mallek JA, et al: Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum 54: 621-627, 2006.
23. Sartor RB: Microbial infl uences in infl ammatory bowel diseases. Gastroenterology 134: 577-594, 2008.
24. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ and Powrie F: Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371-1375, 2010.
25. Hirota K, Turner JE, Villa M, Duarte JH, Demengeot J, Steinmetz OM and Stockinger B: Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol 14: 372-379, 2013.